APA

Dossenbach M., Pecenak J., Szulc A., Irimia V., Anders M., Logozar-Perkovic D., Peciukaitiene D., Kotler M., Smulevich A. B., West T. M., Lowry A. J. & Treuer T. (20090306). Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study. : The Journal of clinical psychiatry.

Chicago

Dossenbach Martin, Pecenak Jan, Szulc Agata, Irimia Victoria, Anders Martin, Logozar-Perkovic Dusanka, Peciukaitiene Dalia, Kotler Moshe, Smulevich Anatoly B, West Teena M, Lowry Amanda J and Treuer Tamas. 20090306. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study. : The Journal of clinical psychiatry.

Harvard

Dossenbach M., Pecenak J., Szulc A., Irimia V., Anders M., Logozar-Perkovic D., Peciukaitiene D., Kotler M., Smulevich A. B., West T. M., Lowry A. J. and Treuer T. (20090306). Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study. : The Journal of clinical psychiatry.

MLA

Dossenbach Martin, Pecenak Jan, Szulc Agata, Irimia Victoria, Anders Martin, Logozar-Perkovic Dusanka, Peciukaitiene Dalia, Kotler Moshe, Smulevich Anatoly B, West Teena M, Lowry Amanda J and Treuer Tamas. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study. : The Journal of clinical psychiatry. 20090306.